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Purpose: To evaluate the efficacy of excision of avascular bleb and advancement of adjacent conjunctiva (EBAC) 
for treatment of hypotony after trabeculectomy with mitomycin C (MMC). 
Methods: Fifteen patients (17 eyes) who received EBAC for correction of hypotony between September 1996 and 
October 2008 were reviewed retrospectively. The main outcomes were intraocular pressure (IOP) and postoperative 
complications. 
Results: Hypotony (IOP <6 mmHg) of eight eyes (47.1%, seven patients) was caused by bleb perforation. Of these, 
two eyes (two patients) had a history of trauma. Hypotony appeared at 33.9±30.8 months, and EBAC was performed 
at 48.2±35.3 months after trabeculectomy with MMC. The mean follow-up period was 38.3±29.8 months. The qualified 
success rate of EBAC was 100% at 51 months after EBAC, and the complete success rate of EBAC was 76.5% at 
six months and 70.6% at 51 months, as determined by Kaplan-Meier analysis. Post-EBAC complications included 
blepharoptosis in four eyes (23.5%) and bleb perforation in one (5.9%). The blepharoptosis resolved within one 
month after EBAC in two patients. However, in the other patients, mild blepharoptosis remained at 17 and 22 months 
postoperatively.
Conclusions: EBAC was found to be an effective method for treatment of hypotony after trabeculectomy with MMC, 
and postoperative blepharoptosis was a major complication. 
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The goal of trabeculectomy is to reduce intraocular pre-
ssure (IOP) to a level that will prevent further optic nerve 
damage, while avoiding complications from ocular hypotony. 
The adjunct use of mitomycin C (MMC) with trabeculectomy 
increases the likelihood of maintaining a low IOP.
1  However, 
it also increases the incidence of complications such as 
shallow anterior chamber, progression of cataract, ciliocho-
roidal effusion, and bleb leaks.
2-4 Trabeculectomy with adjunct 
use of MMC may have an even higher rate of late bleb leaks 
than those with adjunct use of 5-fluorouracil (5-FU),
5,6 
since trabeculectomy with MMC can produce extremely thin, 
avascular blebs.
6
Conservative treatments associated with bleb leaks and 
overfiltration are usually attempted first, including aqueous 
suppressants, antibiotics, oversized contact lenses,
7 cyanoa-
crylate glue,
8,9 pressure patching, and autologous blood in-
trableb injection.
10-13 However, these procedures have a limited 
success rate.
14,15  Effective treatment of hypotony often requires 
surgical management,
16 usually by advancement of conjunctiva 
from the adjacent conjunctiva and/or Tenon layers
17-25  or by 
free conjunctival autografts.
26,27 The goal of surgery is to seal 
bleb leaks and overfiltration while preserving a functioning 
filtering bleb, and several studies have reported that surgical 
management has a 83-96% success rate, although success 
was defined differently in each study.
28,29
We previously reported a method of bleb revision for 
hypotony caused by leaking or overfiltrating blebs, in which 
bleb excision and advancement of the fornical conjunctiva 
was performed to correct hypotony in five patients. Intraocular 
pressure increased and visual acuity (VA) improved after 
operation.
30 The purpose of this study was to evaluate the 
effects of excision of avascular bleb and advancement of 
adjacent conjunctiva (EBAC) for treatment of hypotony after 
trabeculectomy with MMC. 
Materials and Methods
A retrospective review was conducted of 17 eyes (15 
patients) that underwent EBAC for correction of hypotony 
after trabeculectomy with MMC at Chungbuk National 
University Hospital between September 1996 and October 
2008. All patients had minimum of six months of follow-up Korean J Ophthalmol Vol.23, No.4, 2009
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Table 1. Demographics and clinical characteristics
Age (yr) 41.9±14.2
Gender 　
   Male 14
   Female 1
Right eye : Left eye 6:11
Bleb perforation 8 (47%)
Hx of ocular trauma 2 (11.8%)
Interval between TrabMMC and hypotony (mon) 33.9±30.8
Interval between TrabMMC and EBAC (mon) 48.3±35.3
Follow-up period (mon) 38.3±29.8
Values are presented as mean±SD or number (%). 
Hx=history; TrabMMC=trabeculectomy with mitomycin C.
Table 2. Diagnoses of glaucoma patients
Type of glaucoma   No. of eyes %
Primary open-angle glaucoma  9 52.9
Secondary glaucoma  8 47.1
   Neovascular glaucoma  4 23.6
   Pigmentary glaucoma 1  5.9
   Glaucoma following ocular surgery  1  5.9
   Uveitic glaucoma  1  5.9
   Posner-Schlossman syndrome   1  5.9
Total 17 100
Fig. 1. Scatter plot of preoperative intraocular pressure (IOP) and 
IOP at final follow-up. Mean preoperative IOP was 2.8±2.1 mmHg 
and mean IOP at final follow-up was 12.2±3.2 mmHg. IOP was 
significantly higher at final follow-up (p<0.001, t-test).
EBAC=excision of avascular bleb and advancement of adjacent 
conjunctiva.
after EBAC.
We investigated the patient medical records and noted 
demographic and clinical characteristics including IOP, VA, 
type of glaucoma, gender, age at the time of EBAC, and 
history of trauma and bleb perforation. Duration of trabecu-
lectomy with MMC and hypotony and duration of trabecu-
lectomy with MMC and EBAC were investigated. Operative 
and postoperative courses were noted, especially duration of 
follow-up, IOP, VA, bleb appearance and complications.
EBAC was performed under Nadbath’s akinesia, with a 
sub-Tenon injection of 2% lidocaine. Anterior chamber pa-
racentesis was placed at either the 3 or 9 o’clock position. 
The thinned avascular conjunctival bleb was excised. The 
healthy conjunctiva and Tenon capsule between the superior 
border of the excised bleb and the superior fornix were used 
to reconstruct the new bleb. One or two horizontal relaxing 
incisions in the fornix were made that were long enough 
to permit coverage of the filtration site without tension. 
The conjunctiva and Tenon capsule anterior to the relaxing 
incision were undermined, and the Tenon flap was carefully 
advanced to the limbus, avoiding formation of a button hole, 
and sutured to the limbus. Following this, the limbal margin 
of the conjunctival flap was sutured separately with 10-0 
Nylon.
Hypotony was defined as an IOP below 6 mmHg lasting 
for one month or longer. EBAC was considered a complete 
success (CS) when the complication was resolved while 
maintaining an IOP ≥6 mmHg and ≤18 mmHg without the 
use of glaucoma medication. Qualified success (QS) was 
achievement of the above with glaucoma medications but 
with no need for reoperation for glaucoma. The date of failure 
was considered the first visit in which recurrence or persis-
tence of the complication (hypotony, leaks) or IOP >18 mmHg 
was noted.
Statistical analysis was carried out using SPSS ver. 
13.0 (SPSS Inc., Chicago, IL, USA), and a p-value less 
than 0.05 was considered statistically significant.
Results
The mean age of the patients (14 men and one woman) 
was 41.9±14.2 years (range, 15 to 66 years). The mean time 
interval between trabeculectomy with MMC and occurrence 
of hypotony was 33.9±30.8 months with a range of 1 day to 
89 months. The mean time interval between trabeculectomy 
with MMC and EBAC was 48.3±35.3 months (range, 0 to 
89 months). Hypotony of eight eyes (47.1%) of seven 
patients was caused by bleb perforation; of these, two 
eyes in two patients had a history of trauma. Mean follow- 
up after EBAC was 38.3±29.8 months (range, 9 to 104 
months) (Table 1). Primary open-angle glaucoma was the 
most common glaucoma type (nine eyes, 52.9%), followed 
by neovascular glaucoma (four eyes, 23.6%), pigmentary 
glaucoma (one eye, 5.9%), uveitic glaucoma (one eye, 
5.9%), Posner-Schlossman syndrome (one eye, 5.9%), and 
glaucoma following ocular surgery (one eye, 5.9%) (Table 2).
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Fig. 2. Scatter plot of preoperative visual acuity (VA) and VA at final
follow-up. Mean preoperative VA (logMAR) was 1.02±1.04 and 
mean VA (logMAR) at final follow-up was 0.54±0.97. Differences 
were not significant (p=0.243, t-test).
EBAC=excision of avascular bleb and advancement of adjacent 
conjunctiva.
Fig. 3. Kaplan-Meier analysis of success rate of excision of avas-
cular bleb and advancement of adjacent conjunctiva. Criteria for 
complete success were intraocular pressure (IOP) ≥6 mmHg and ≤
18 mmHg with the use of no glaucoma medications. Criteria for 
qualified success were the same as that for complete success but with 
use of glaucoma medication to control IOP.
Table 3. Postoperative complications of excision of 
avascular blebs and advancement of adjacent conjunctiva
Postoperative complication No. of eyes %
Bleb perforation 1  5.9
Blepharoptosis 4 23.5
   with hypertropia 3 17.6
   without hypertropia 1  5.9
Total 5 29.4
mean IOP at last follow-up was 12.2±3.2 mmHg (p<0.001, 
t-test) (Fig. 1). The mean preoperative VA (logMAR) was 
1.02±1.04, and the mean VA (logMAR) at the final follow- 
up was 0.54±0.97 (p=0.174,  t-test) (Fig. 2).
Kaplan-Meier survival analysis was used to measure the 
QS and CS rates of EBAC. Qualified success was obtained 
for all 17 eyes at 51 months follow-up, although five patients 
required glaucoma medication for IOP control. EBAC gave 
a CS rate of 76.5% at six months and 70.6% at 51 months 
follow-up (Fig. 3). At the final follow-up after EBAC, 12 
(70.6%) of 17 eyes had thick walled blebs; and one had a 
partially translucent bleb. Diffuse and partially translucent 
blebs were maintained in three eyes (17.6%), a bleb was not 
maintained in one eye (5.9%) and a diffuse avascular bleb 
in one eye (5.9%) showed bleb perforation at 89 months after 
EBAC.
Complications from EBAC included blepharoptosis in four 
eyes (23.5%), one of which had hypertropia. Blepharoptosis 
of two patients without hypertropia was resolved in one month 
with no management. In one patient without hypertropia, 
mild blepharoptosis remained at the 22-month follow-up after 
EBAC. In one patient with hypertropia, mild blepharoptosis 
and hypertropia remained at 17 months after EBAC. Hyper-
tropia was small (<10 prism diopter) and conservative ma-
nagement was performed. Bleb perforation was seen in one 
eye (5.9%) at 89 months after EBAC, and the patient under-
went reoperation (Table 3). No other postoperative compli-
cations such as endophthalmitis, suprachoroidal hemorrhage, 
choroidal effusions, or shallow anterior chamber occurred.
Discussion
Trabeculectomy is commonly conducted when medical 
therapy fails to control IOP. The introduction of adjunctive 
5-fluorouracil (5-FU) and MMC has resulted in improvement 
of IOP control for eyes that had lower rates of operative 
accomplishment and for uncomplicated glaucoma.
1,31 However, 
adjunctive use of MMC may cause a higher incidence of 
postoperative hypotony and hypotonic maculopathy.
3,4
Trabeculectomy conducted with MMC may have a higher 
rate of bleb leaks than trabeculectomy conducted with 5-FU.
6 
Histopathological examination of blebs after trabeculectomy 
with MMC revealed irregularities in the conjunctival epithe-
lium, breaks in the basement membrane, and conjunctival 
and subconjunctival hypocellularity, each of which may be 
a predisposing factor for bleb leaks and overfiltration.
32 
With managing hypotony, observation is appropriate in the 
absence of complications. Seah et al.
33 reported that hypotony 
is common after trabeculectomy but usually persists for less 
than two weeks. Only patients with prolonged hypotony had 
a VA decline, suggesting that if the IOP remains below the 
physiological tolerance for over two months, treatment of 
hypotony should be attempted. Complications that increase 
the urgency of treatment for bleb leaks and hypotony include 
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decline of VA with macular folds, present or previous blebitis, 
a shallow anterior chamber, and profound hypotony. In our 
study, the mean time between hypotony and EBAC was 13.6 
±25.0 month (range, 0 to 99 months). Seven eyes had bleb 
leaks, one had a decreased VA only, one had a decreased 
VA with a macular fold, and the others had hypotony for 
over two months.
Management of bleb leaks and overfiltrating blebs overlaps 
because both indicate excessive filtration of aqueous humor. 
The first treatments are usually conservative,
6,10  but these 
have a limited success rate.
14,15 When conservative manage-
ment fails, surgical management is required. Dunnington and 
Regan
17 described a series of 15 patients with either inadver-
tent or intentional filtering blebs who underwent conjunctival 
advancement for bleb leaks. Geijin et al.
25 described a success 
rate of 86.1% for 36 patients who underwent excision of 
conjunctiva and advancement of conjunctiva and Tenon cap-
sule for bleb leaks or overfiltrating bleb. The IOP increased 
from 4.3 mmHg to 13.5 mmHg after operation. Burnstein et 
al.
34 compared conjunctival advancement and nonincisional 
treatment for filtering bleb leaks. Conjunctival advancement 
was more likely to control IOP effectively and was less 
likely to have serious complications like endophthalmitis, 
than was management with nonincisional treatment. We con-
ducted EBAC in 17 eyes that had hypotony after trabeculec-
tomy with MMC. Intraocular pressure increased from 2.8 
mmHg to 12.2 mmHg at the final follow-up (p<0.001). VA 
(logMAR) decreased from 1.02 to 0.54 at the final follow- 
up, but these differences were not significant.
Budenz et al.
35 compared the safety and efficacy of pre-
served human amniotic membrane transplants with conjunctival 
advancement for repair of late-onset bleb leaks. The cumu-
lative survival for amniotic membrane transplant was 81% 
at six months, 74% at one year, and 46% at two years, and 
the cumulative survival for conjunctival advancement was 
100% throughout the follow-up period. Tannenbaum et al.
29 
described the effect of bleb excision and conjunctival ad-
vancement for leaking or hypotonous eyes after trabeculec-
tomy or combined operation and found that bleb excision 
and conjunctival advancement successfully managed leaks 
and hypotony. Complete success was obtained for 40% of 
patients and QS was obtained for 83% of patients. In our 
study, EBAC eliminated bleb leaks and hypotony effectively. 
Qualified success was 100% throughout the follow-up, 
and CS was 76.5% at six months and 70.6% at 51 months. 
Replacement of the abnormal conjunctiva with a normal 
healthy conjunctiva restores the normal epithelial barrier and 
appears to be the most successful physiological therapy for 
reversing hypotony. It is relatively safe because manipulation 
is extraocular, and additional manipulation of the scleral 
flap is not needed. 
Scleral patch graft or amniotic membrane transplantation 
could be performed for treatment of hypotony, but donor 
sclera or amniotic membrane may be virally contaminated, 
so special preservation and care are needed.
36 Also, adequate 
donor tissue or amniotic membrane is not always available. 
EBAC does not require donor tissue or amniotic membrane.
Complications of EBAC are an immediate postoperative 
IOP spike, recurrent bleb leaks, bleb dysesthesia, bleb failure, 
hypertropia and blepharoptosis.
24,28-30,34 We found that surgery 
can cause adverse events, but they were uncommon. We 
experienced four cases of blepharoptosis and one case of bleb 
perforation. One case of blepharoptosis was combined with 
small hypertropia. Two cases of blepharoptosis resolved in 
2 months after EBAC. In the other cases, blepharoptosis im-
proved, although mild blepharoptosis remained. Blepharoptosis 
and hypertropia were probably due to tension from an in-
sufficient relaxing incision in the fornix.
Some studies report that initial VA is often not restored 
in some hypotony patients, despite treatment. Prolonged hy-
potony is thought to cause irreversible chorioretinal folds 
from fibrosis within the retina, choroids, or sclera.
4 In our 
study, three eyes from two patients had no restoration of 
preoperative VA. Neovascular glaucoma due to proliferative 
diabetic retinopathy was present in one patient and Eales’ 
disease in the other.
Generally, hypotony has numerous complications, and pre-
vention is the best treatment. We were able to obtain proper 
control of IOP and maintenance of initial VA without serious 
complications. In conclusion, EBAC was an effective and safe 
procedure for treatment of hypotony after trabeculectomy 
with MMC.
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